Navigation Links
DRAXIS Obtains Final Order for Proposed Arrangement
Date:5/27/2008

Court approves acquisition of DRAXIS by Jubilant

TORONTO, May 27 /PRNewswire-FirstCall/ - DRAXIS Health Inc. ("DRAXIS") (TSX: DAX) (NASDAQ: DRAX) announced today that it has obtained a Final Order from the Quebec Superior Court in connection with the previously announced proposed statutory plan of arrangement under which all of DRAXIS' common shares will be acquired by an indirect wholly-owned subsidiary of Jubilant Organosys Ltd ("Jubilant") for US$6.00 per common share. The arrangement was approved by 99% of the votes cast by holders of DRAXIS' common shares, which was in excess of the 66 2/3% required, at the annual and special meeting of DRAXIS shareholders held May 23, 2008.

The transaction is expected to close shortly. The transaction remains subject to customary closing conditions.

About DRAXIS Health Inc.:

DRAXIS Health, through its wholly owned operating subsidiary, DRAXIS Specialty Pharmaceuticals Inc., provides products in three categories: sterile products, non-sterile products and radiopharmaceuticals. Sterile products include liquid and freeze-dried (lyophilized) injectables plus sterile ointments and creams. Non-sterile products are produced as solid oral and semi-solid dosage forms. Radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications. Pharmaceutical contract manufacturing services are provided through the DRAXIS Pharma division and radiopharmaceuticals are developed, produced, and sold through the DRAXIMAGE division. DRAXIS employs approximately 500 staff in its Montreal facility.
For additional information please visit http://www.draxis.com

Caution Concerning Forward-Lookin
'/>"/>

SOURCE DRAXIS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
2. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
3. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
4. DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
5. DRAXIS Announces Application for Normal Course Issuer Bid
6. DRAXIS Share Buyback Approved by TSX
7. DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th
8. DRAXIS Health Reports Fourth Quarter and Year End Results
9. DRAXIS Responds to Trading
10. Jubilant to acquire Draxis Health
11. DRAXIS Obtains Interim Order for Proposed Arrangement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire/--TheBlackAIDSInstituterecentlyheldBoardo...r2010. ,, ThenewBoardMembersareahighlydiversegr...nce,governmenthealthprograms,editorial,andbusiness...personalbackgroundsincludingbothheterosexualandgay...presentingmultipleagegroups. ,, (Photo: http://...
(Date:11/25/2009)...statistically significant survival benefit from ad...eptor (ER)-positive tumors had high levels of phos...118-P), according to a brief communication publish...nal Cancer Institute . , Approximately 50% of br...nical studies have shown that ER-alpha S118-P is r...
(Date:11/25/2009)...toid arthritis, could help newly diagnosed diabeti...HealthDay News) -- A drug commonly used to treat n... also shows some promise in helping patients newly...tuximab (Rituxan), helped patients keep producing ... had destroyed some of their pancreatic beta cells...
(Date:11/25/2009)...ns of trouble with the H1N1 vaccine, , ,...ng H1N1 swine flu pandemic may be driving a recent...nts, a U.S. health official said Wednesday. , "...infections around the country," Dr. Anne Schuchat,...and Respiratory Diseases at the U.S. Centers for D...
(Date:11/25/2009)...carried into the body on a carefully engineered, f...ly eliminate tumors in mammals, scientists report ...dicine . , The new approach, pioneered by bioeng...es plastic disks impregnated with tumor-specific a...the mammalian immune system to attack tumors. The ...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
... Dr. Steriani Elavsky, women passing through their...f life// when they exercised. The improvements in ...ositive effect on their perceived quality of life....rform Yoga while the second group was asked to wal...
...alth insurance does not seem to help people when i...tionwide. This study was funded// by W.K. Kellogg ... The Access Project of Boston has reported the...mplicated insurance policies and routine denial of...
...has been reduced in order to increase their effici...edics found that cutting down working hours alone ... in the design of rotas was essential. The O... junior doctors will have to work only 48 hours in...
...O) has claimed that the global tuberculosis (TB) e...it declared TB a public health emergency in 1993. ...sed today, two days before the world TB day, says ...on described the development as a culmination of t...
...ates suggests that the odds of firefighters dying ...hting a fire, //are 10 to 100 times higher than du...rom a tree. Stefanos Kales of Harvard Medica...eared responsible for it. Even though fire su...
...cancer through testing saliva samples, U.S. resear...ished in the latest issue of the General Dentistry...rotein levels in saliva have a great potential to ...is a clear, colorless liquid, while blood undergoe...
Other Medicine News:Health News:Rest for Doctors to Ensure Patients’ Safet 2Health News:Global Tuberculosis Epidemic Levelling Off - WHO 2Health News:New Study Reveals That Firefighters Are Prone To Heart Attack 2
(Date:11/25/2009)...A,Nov.25/PRNewswire-FirstCall/--ERT(Nasdaq: ERES )...,sPresidentandCEO,andKeithSchneck,theCompany,sExec...e21stAnnualPiperJaffrayHealthCareConferenceat1:30P...nterestedpartiesmayaccessthepresentationbyvisiting....Thewebcastmayalsobeaccessedat http://www.corporat...
(Date:11/25/2009)...,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtraditional...-nucleosidereversetranscriptaseinhibitor(NNRTI).IN...treatment-experiencedadultswhoareexperiencingvirol...herantiretroviral(ARV)agents.Thetraditionalapprova...ET-1andDUET-2.INTELENCEiscurrentlymarketedintheU.S...
(Date:11/25/2009)...VA,Calif.,Nov.25/PRNewswire/--AMPACFineChemicalsLL...daq: APFC )announcedtodaythatitreceivedtheEnvironm...alStatewideEnvironmentalSummit,sponsoredbytheCalif...heIndustrialEnvironmentalAssociation(IEA)andtheChe...go.Thisisthemostprestigiousawardavailablefromallth...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 1Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 2Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 3Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 4Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 5GSK Improving Performance to Continue in Second Half 52381 1Red Mango Introduces the First Probiotic Iced Tea July 27 52379 1Red Mango Introduces the First Probiotic Iced Tea July 27 52379 2Red Mango Introduces the First Probiotic Iced Tea July 27 52379 3Red Mango Introduces the First Probiotic Iced Tea July 27 52379 4
... April 12, 2007--The costs of eradicating,poliomye... high in,the short term, are much lower than the l...hout eradication. And a recently developed,monoval...gainst,type 1 poliomyelitis than an existing triva...es published Online and in an upcoming,issue of Th...
... April 11 /CNW/ - Liponex Inc. (TSX:LPX), a,biopha...anced,products related to High Density Lipoprotein...ounced information from further,analysis of the Ph... CRD5 is being developed for the treatment of dysl... patient information indicated that all,blood chem...
Other Medicine Technology:Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 2Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 3
...eTak is a 3 mm bioabsorbable push-in suture anchor...sue attachment to bone in the shoulder joint and o... high pull-out strength is required. The exclusive...y of the anchor and provides superior resistance t...
...ure is a new generation of polyester suture with a...er strength than similar sized polyester suture wi...t profile. FiberWire is the ideal suture for most ...ting suture breakage during knot tying.,All sizes...
FiberLoop™
Flowstar Uroflowmeter
Medicine Products: